Developing small molecules to address unmet medical needs
Inositec AG
Incorporated
21.12.2015Headquarters
ZurichSupport
Inositec is pioneering the development of life-saving small molecule drugs based on inositol phosphate, a natural facilitator of diverse cellular functions. Using its broadly applicable InosituneTM technology to adjust the chemical and physical properties of inositol phosphate (IP6) analogs, Inositec is developing a novel class of drugs currently focusing on high-unmet medical needs related to calcification disorders. The lead compound INS-3001 is a cardiovascular calcification inhibitor in development for aortic valve stenosis. Inositec was founded in December 2015 based on the award-winning research of Dr. Mattias Ivarsson, Prof. Jean-Christophe Leroux and Prof. Bastien Castagner at ETH Zurich, Switzerland. Further information can be found at www.inositec.com.
News
Vifor Pharma to acquire Inositec (startupticker.ch)
Inositec gets acquired by Vifor Pharma to advance the vascular calcification field (venturelab.swiss)
Successful proof-of-concept for Inositec's lead candidate (startupticker.ch)
Seven startups receive the first Innosuisse Certificates (startupticker.ch)
Inositec to launch clinical studies for its drug against kidney-related issues (startupticker.ch)
Prix Strategis 2018: Les 5 finalistes sont connus (startupticker.ch)
Evolving Startups expand management teams (startupticker.ch)
Prix Strategis: Die acht Semifinalisten stehen fest (startupticker.ch)
Schweizer Technologieprojekte ausgezeichnet (startupticker.ch)
Swiss Technology Award: Die Finalisten stehen fest (startupticker.ch)
15 Swiss startups to present at Swiss Biotech Day (startupticker.ch)
15 Swiss startups to present at Swiss Biotech Day (startupticker.ch)
Inositec Secures CHF1.4 million in Seed Financing (startupticker.ch)
Foundation for Promotion of the National Economy supports Pregnolia and Inositec (startupticker.ch)
Winners of the W.A. de Vigier Award: Groundbreaking Technologies – Made in Switzerland (startupticker.ch)
Ten startups nominated for the W. A. Vigier award (startupticker.ch)
Je 150‘000 Franken für drei Life Sciences Startups (startupticker.ch)
Finalisten für den Heuberger Winterthur Jungunternehmerpreis bestimmt (startupticker.ch)
And the winners of >>venture>> 2015 are: CUTISS and Pregnostics (startupticker.ch)
Swiss National Start-up Team Ready for a Trip to the US (startupticker.ch)
